Deregulation of protein tyrosine phosphatases (PTPs) or protein tyrosine kinases (PTKs) leads to aberrant tyrosine phosphorylation, which has been implicated in the etiology of several diseases, including prostate cancer (8–10). Here, PTEN is linked to prostate cancer.